Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life
Corporate - Media & Press - Press Release
Arrayit makes strong Inc. 500 move in 2003.
Sunnyvale, CA, October 27, 2003 – On October 15th, Inc. Magazine announced that Arrayit was once again chosen as one of the top 500 fastest growing private companies in America. Arrayit’s position on the Inc. 500 list advanced from 457 in 2002 to 248 in 2003, representing an impressive gain of 209 positions during the past year. This year’s Inc. 500 list is the 22nd annual ranking of the fastest-growing companies in America, and more than 20,000 prospective businesses were contacted before the top 500 were chosen. Arrayit is the only Life Sciences company in the United States to make the list in 2003. The company continues to excel in a highly competitive marketplace by innovating and by providing superior technology and services to the academic, biotechnology, industrial, and medical diagnostics communities. Arrayit organizes its business activities into Life Sciences (ArrayIt®), Chemicals, and Diagnostics divisions. The company achieved 697% growth in the stringent 5-year analysis period.
René Schena, CEO of Arrayit expands her comments in the Inc. 500 feature article. "In 1996, our Executive Vice-President, Todd Martinsky, suggested we expand into the Life Sciences market. At that time, chemical import and export was our primary business focus, but we embraced the expansion efforts. During the past six years, we have developed the ArrayIt® brand name with more than 250 innovative products. We have 150 more currently in the product pipeline. I attribute our success to sound fiscal management, technological innovation, aggressive marketing, and teamwork. We have sensational talent at every level in the company, and to have moved up the Inc. 500 list as quickly as we have validates our approach. I have every expectation that 2004 will see the same continuing success."
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley. Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications. Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services. The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.
Copyright 1993-2019 Arrayit Corporation. All rights reserved.